3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Skin Neoplasms
1
Dysplastic Nevus Syndrome
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Interventions
HhAntag691
15
sonidegib
5
cemiplimab
5
Nivolumab
5
Aminolevulinic Acid
5
daromun
4
Specimen Handling
4
Radiotherapy
3
Magnetic Resonance Spectroscopy
3
3-ingenyl angelate
3
tazarotene
2
relatlimab
2
Ipilimumab
2
IPI-926
2
Drug Evaluation
2
Celecoxib
2
Biopsy
2
talimogene laherparepvec
1
remetinostat
1
gusacitinib
1
endonuclease V, phage T4
1
X-Rays
1
Triamcinolone
1
Sutures
1
Surgical Procedures, Operative
1
Solutions
1
Papillomavirus Vaccines
1
Opdualag
1
Observation
1
Niacinamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Basal Cell
×
Sutures
×
Clear all
NCT00586040
2009-04-10
PTB
Massachusetts General Hospital
Phase 2
Completed
40 enrolled